Bio-Rad Labs (BIO) Misses Q3 EPS by 18c

Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $2.60, $0.18 worse than the analyst estimate of $2.78. Revenue for the quarter came in at $680.8 million versus the consensus estimate of $679.94 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Hitachi Ltd. (HIT) Misses Q2 EPS by 7c